The consensus ordinary profit forecast for Kissei Pharmaceutical Co., Ltd. for the fiscal year ending March 2027 fell 2.3% week on week to ¥4,874 million. It remains above the company's forecast of ¥4,000 million, while the rating consensus was unchanged at 3.5.
The market consensus for Kissei Pharmaceutical Co., Ltd.'s ordinary profit forecast for the fiscal year ending March 2027 fell 2.3% week on week to ¥4,874 million. The previous week's figure was ¥4,992 million.
The current consensus is viewed as being above the company's published forecast of ¥4,000 million.
The information indicates that the company's rating consensus was unchanged at 3.5.
The text names Tsumura, Seikagaku Corporation, Zeria Pharmaceutical Co., Ltd. and Towa Pharmaceutical Co., Ltd. as related stocks.